Abstract: Tetanus is a distressing and often fatal disease caused by exotoxins released by the bacterium . is a commensal of the gastrointestinal tract of humans and domestic animals, and its spores are highly resistant to environmental changes, acid, and alkali and may persist in the soil for many years. The disease is characterized by generalized muscular rigidity and spasms, hyperesthesia, convulsions, respiratory arrest, and death. Horses are the most susceptible domestic animals. Treatment is typically directed towards elimination of the source of the toxin, neutralization of any unbound toxin, establishment of antitoxin immunity, control of neuromuscular derangements, and relief of pain. This study described the clinical findings and therapeutic protocols of 17 horses with tetanus, treated between March 2012 and December 2021. The diagnosis of tetanus was based on the history and clinical examination findings of the animals. All horses received a treatment pattern composed of the administration of tetanus serum (50,000 UI, intravenously, followed by three injections of the same dose at 48-h intervals), procaine penicillin (25,000 UI kg, intramuscularly, BID, for 10 days), and muscle relaxant (acepromazine 0.02-0.05 mg/kg, intramuscularly, BID, for 8 days). Support therapy based on hydroelectrolytic replacements, feeding via a nasogastric tube, and assistance in the maintenance of the quadrupedal position were performed when needed. The mortality rate observed in this report was 23.52%. Early diagnosis associated with the instituted treatment contributed the most to the animal recovery. O tétano é uma doença angustiante e frequentemente fatal, causada por exotoxinas liberadas pela bactéria . é um microrganismo comensal do trato gastrointestinal do homem e de animais domésticos, e seus esporos são altamente resistentes às mudanças ambientais, ácidas e alcalinas, podendo persistir no solo por muitos anos. A doença é caracterizada por rigidez muscular generalizada e espasmos, hiperestesia, convulsões, parada respiratória e morte. O cavalo é a espécie de animal doméstico mais suscetível. O tratamento é tipicamente direcionado à eliminação da fonte da toxina, neutralização de qualquer toxina não ligada, estabelecimento de imunidade à antitoxina, controle de distúrbios neuromusculares e alívio da dor. Os achados clínicos e protocolos terapêuticos de 17 cavalos com tétano tratados durante o período de março de 2012 a dezembro de 2021 são descritos. O diagnóstico de tétano baseou-se na história e nos achados do exame clínico dos animais. Todos os cavalos receberam padrão de tratamento, composto pela administração de soro tetânico (50.000UI, por via intravenosa, seguido de três outras aplicações da mesma dose em intervalos de 48 horas), penicilina procaína (25.000UI kg, intramuscular, BID, por 10 dias) e relaxante muscular (acepromazina 0,02-0,05 mg kg, por via intramuscular, BID, por oito dias). Foram realizadas terapia de suporte baseada em reposições hidroeletrolíticas, alimentação por sonda nasogástrica e auxílio na manutenção da posição quadrúpede, quando necessário. A mortalidade observada neste estudo foi de 23,52%. O diagnóstico precoce associado ao tratamento instituído foram os fatores que mais contribuíram para a recuperação dos animais.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study discusses the clinical findings and treatment regimens of 17 cases of tetanus in horses. It notes that the early diagnosis and instituted treatment play a significant role in the recovery of the animals.
Introduction
Tetanus is a deadly disease caused by exotoxins released by a particular type of bacterium. This bacterium usually resides in the gastrointestinal tract of humans and domestic animals. Its spores can survive in almost any type of environment, including acidic and alkaline conditions, and may remain in the soil for many years. Horses are the most at-risk domestic animals for this disease, which can cause muscle rigidity, convulsions, hyperesthesia, respiratory arrest, and even death.
Methods
The study focused on 17 horses diagnosed with tetanus based on their medical history and clinical examination findings.
All these animals were treated between March 2012 and December 2021.
The specific treatment administered included a combination of tetanus serum, procaine penicillin, and a muscle relaxant (acepromazine).
The tetanus serum was given intravenously, initially, and then followed by three injections at 48-hour intervals.
The procaine penicillin was administered intramuscularly, two times a day for ten days.
The muscle relaxant was also given intramuscularly, two times a day for eight days.
Supportive Care
When required, additional supportive care was provided to the horses. This included hydroelectrolytic replacements, feeding through a nasogastric tube, and help in maintaining a quadrupedal position.
Results
The mortality rate observed among the treated cases was 23.52%.
The study suggests that an early diagnosis of tetanus in horses, along with the given treatment regimen, was crucial for animal recovery.
Conclusion
This study underscores the importance of prompt diagnosis and treatment in managing horse tetanus cases. The findings should serve as a valuable input for veterinary professionals and may help in reducing fatalities associated with the disease.
Cite This Article
APA
de Melo UP, Ferreira C.
(2022).
Clinical findings and response to treatment of 17 cases of tetanus in horses (2012-2021).
Braz J Vet Med, 44, e005321.
https://doi.org/10.29374/2527-2179.bjvm005321
Veterinarian, DSc. Centro Universitário Uninassau. Natal, RN. Brazil.
Ferreira, Cintia
Veterinarian, DSc. Centro Universitário Uninassau. Natal, RN. Brazil.
Conflict of Interest Statement
Conflict of interest: The authors declare that there are no conflicts of interest regarding the preparation of this manuscript.
References
This article includes 19 references
Almas T, Niaz MA, Zaidi SMJ, Haroon M, Khedro T, Alsufyani R, Al-Awaid AH, Tran E, Khan AW, Alaeddin H, Rifai A, Manamperi KT, Khan A, Haadi A. The Spectrum of Clinical Characteristics and Complications of Tetanus: A Retrospective Cross-Sectional Study From a Developing Nation.. Cureus 2021 Jun;13(6):e15484.
Altıparmak B, Uysal Aİ, Yaşar E, Demirbilek S. [Alternative approach to autonomic instability of very severe tetanus: stellate ganglion block].. Braz J Anesthesiol 2018 Mar-Apr;68(2):209-211.
Di Filippo P. A., Graça F. A. S., Costa A. P. D., Coutinho I. S., Viana I. S.. Clinical and epidemiological findings and response to treatment of 25 cases of tetanus in horses occurred in Norte Fluminense, Rio de Janeiro, Brazil.. Brazilian Journal of Veterinary Medicine 2016;38(1):33–38.
Furr M., Reed S.. Disorders associated with Clostridial neurotoxins: Botulismo and tetanus. Equine Neurology 2nd. Wiley Blackwell; 2015. pp. 319–327.
George E. K., Jesus O., Vivekanandan R.. Clostridium tetani. StatPearls StatPearls Publishing; 2021.
Gračner D., Barbić L., Bijader I., Čolig P., Gračner G. G., Selanec J., Zobel R., Stevanović V., Samardžija M.. A twenty-year retrospective study of tetanus in horses: 42 cases. Veterinarski Arhiv 2015;85(2):141–149.
Hanif H, Anjum A, Ali N, Jamal A, Imran M, Ahmad B, Ali MI. Isolation and Antibiogram of Clostridium tetani from Clinically Diagnosed Tetanus Patients.. Am J Trop Med Hyg 2015 Oct;93(4):752-6.
Oliveira R. S., Moraes R. S., Vilela S. E. R., Pereira F. A., Amaral A. V. C., Meirelles-Bartoli R. B., Saturnino K. C., Braga I. A., Ramos D. G. S.. Tetanus in a male mix breed horse from Jataí Municipality, Goiás: Case report. Research, Social and Development 2020;9(7):e784974378.
Pereira A. L. A., Gonçalves T. F., Dantas J. B. G., Oliveira M. P. M., Gomes J. B., Tolentino M. L. D. L., Pereira E. A., Martins e Silva K. F., Sousa D. C., Silva M. L., Filho. Tétano em equino: Relato de caso. Pubvet 2019;13(6):a357.
Ribeiro M. G., Nardi G., Júnior, Megid J., Franco M. M. J., Guerra S. T., Portilho F. V. R., Rodrigues C. A., Paes A. C.. Tetanus in horses: An overview of 70 cases. Pesquisa Veterinária Brasileira 2018;38(2):285–293.
Silva J. V. S., Lins J. G. G., Marques A. V. M. S., Sucupira G., Junior, Ferreira L. E. P. A.. Tratamento de tétano em égua gestante. Veterinária e Zootecnia 2020;27(1):1–4.
Steinman A., Haik R., Elad D., Sutton G. A.. Intrathecal administration of tetanus antitoxin to three cases of tetanus in horses. Equine Veterinary Education 2000;12(5):237–240.